标题
Galectins in hematological malignancies
作者
关键词
-
出版物
CURRENT OPINION IN HEMATOLOGY
Volume 20, Issue 4, Pages 327-335
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2013-05-22
DOI
10.1097/moh.0b013e328362370f
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Acute Myeloid Leukemia
- (2017) Journal of the National Comprehensive Cancer Network
- Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia
- (2013) C.-L. Cheng et al. BLOOD
- Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma
- (2013) J. Ouyang et al. BLOOD
- Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management
- (2012) Elias Jabbour et al. AMERICAN JOURNAL OF HEMATOLOGY
- Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma
- (2012) F. Cedeno-Laurent et al. BLOOD
- Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death
- (2012) M. C. Clark et al. BLOOD
- Incidence, risk factors and outcome of histological transformation in follicular lymphoma
- (2012) Annarita Conconi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
- (2012) Koichi Ito et al. CANCER AND METASTASIS REVIEWS
- Targeting Galectin-1 Overcomes Breast Cancer-Associated Immunosuppression and Prevents Metastatic Disease
- (2012) T. Dalotto-Moreno et al. CANCER RESEARCH
- A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease
- (2012) D. J. Laderach et al. CANCER RESEARCH
- Regulatory Circuits Mediated by Lectin-Glycan Interactions in Autoimmunity and Cancer
- (2012) Gabriel A. Rabinovich et al. IMMUNITY
- Galectin-1 Deactivates Classically Activated Microglia and Protects from Inflammation-Induced Neurodegeneration
- (2012) Sarah C. Starossom et al. IMMUNITY
- Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma
- (2012) Diego O. Croci et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Galectin-1 in Melanoma Biology and Related Neo-Angiogenesis Processes
- (2012) Véronique Mathieu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The microenvironment in follicular lymphoma
- (2011) Daphne de Jong et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders
- (2011) J. Ouyang et al. BLOOD
- Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma
- (2011) P. Kamper et al. BLOOD
- Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia
- (2011) Q. Zhou et al. BLOOD
- The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide
- (2011) Mariano F. Zacarías Fluck et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor Galectin-1 Mediates Tumor Growth and Metastasis through Regulation of T-Cell Apoptosis
- (2011) A. Banh et al. CANCER RESEARCH
- Galectins and microenvironmental niches during hematopoiesis
- (2011) Gabriel A. Rabinovich et al. CURRENT OPINION IN HEMATOLOGY
- A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans
- (2011) Shigeru Tsuboi et al. EMBO JOURNAL
- Galectin-3 Protein Modulates Cell Surface Expression and Activation of Vascular Endothelial Growth Factor Receptor 2 in Human Endothelial Cells
- (2011) Anna I. Markowska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic large cell lymphoma cells but not in Hodgkin lymphoma cells
- (2011) Osamu Suzuki et al. LABORATORY INVESTIGATION
- The bone marrow stroma in hematological neoplasms—a guilty bystander
- (2011) Claudio Tripodo et al. Nature Reviews Clinical Oncology
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Galectin-3C Inhibits Tumor Growth and Increases the Anticancer Activity of Bortezomib in a Murine Model of Human Multiple Myeloma
- (2011) Leonardo Mirandola et al. PLoS One
- Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia
- (2011) M. Yamamoto-Sugitani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Galectins: regulators of acute and chronic inflammation
- (2010) Fu-Tong Liu et al. Annals of the New York Academy of Sciences
- GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death
- (2010) M. J. Streetly et al. BLOOD
- Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity
- (2010) V. L. Thijssen et al. CANCER RESEARCH
- Modulation of endothelial cell migration and angiogenesis: a novel function for the “tandem-repeat” lectin galectin-8
- (2010) Víctor M. Cárdenas Delgado et al. FASEB JOURNAL
- Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways
- (2010) T Kobayashi et al. LEUKEMIA
- How I treat EBV lymphoproliferation
- (2009) H. E. Heslop BLOOD
- Update on treatment of cutaneous T-cell lymphoma
- (2009) Jennifer M Gardner et al. CURRENT OPINION IN ONCOLOGY
- Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10
- (2009) Juan M Ilarregui et al. NATURE IMMUNOLOGY
- Galectin-1 supports the survival of CD45RA(−) primary myeloma cellsin vitro
- (2008) Saeid Abroun et al. BRITISH JOURNAL OF HAEMATOLOGY
- AP1-Dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features
- (2008) S. J. Rodig et al. CLINICAL CANCER RESEARCH
- Restoring the Association of the T Cell Receptor with CD8 Reverses Anergy in Human Tumor-Infiltrating Lymphocytes
- (2008) Nathalie Demotte et al. IMMUNITY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started